Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/S1470-2045(20)30439-3 | DOI Listing |
Medicine (Baltimore)
November 2024
Departamento de Ciencias Basicas Medicas, Facultad de Salud, Universidad Icesi, Cali, Colombia.
Pain Res Manag
October 2024
Department of Hospice Care, Shengjing Hospital of China Medical University, Shenyang 110022, China.
Cancer-related pain is a pervasive symptom affecting the quality of life in patients with malignant tumors. For those with refractory pain, palliative sedation combined with pain management is recommended. Dexmedetomidine (DEX), known for its unique "awake sedation" effect, remains relatively unexplored when used in conjunction with patient-controlled analgesia (PCA) for terminal-stage cancer patients.
View Article and Find Full Text PDFAcc Chem Res
November 2024
Division of Endocrinology and Diabetes, Department of Pediatrics, School of Medicine, Stanford University, Stanford, California 94305, United States.
Neurol Sci
October 2024
Department of Neurosciences, AOU "San Giovanni di Dio e Ruggi d'Aragona", Salerno, Italy.
Introduction: Perampanel is a selective non-competitive antagonist of AMPA receptors, and the first agent of this class to become available for the treatment of epilepsy. It could be a useful tool for treatment of refractory status epilepticus (RSE).
Methods: We describe a series of eight RSE cases treated with Perampanel.
BMC Anesthesiol
October 2024
Medical Faculty Heidelberg, Department of Anesthesiology, Heidelberg University, Heidelberg, Germany.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!